July 9, Ninghai – The 14th China Innovation & Entrepreneurship Competition (Ninghai Division) concluded successfully. Zhejiang Tianyuan Biotechnology Co., Ltd. stood out among numerous competing enterprises with its outstanding innovative capabilities and excellent project presentation, securing first place in this competition!

      Organized by the Ninghai County Bureau of Science and Technology, this event aimed to identify technology enterprises with innovation capabilities and high-growth potential, gather entrepreneurial resources, stimulate innovation vitality, leverage the supporting role of technological innovation, and promote economic and social development. Represented by Dr. Chen Junjie, Technical Director, Tianyuan Biotechnology participated with its "iPS Cell Technology and Development Project." The project won unanimous acclaim from the judges for its cutting-edge technical vision, solid technological foundation, and broad application prospects.

      During the roadshow session, Dr. Chen elaborated on the core advantages of iPS cell technology and Tianyuan Biotechnology’s development strategy in the biomedical field. Induced pluripotent stem cells (iPSCs) possess powerful differentiation potential, enabling them to develop into various human cell types. This technology holds tremendous promise for disease treatment, drug development, regenerative medicine, and other fields.

      This award not only recognizes Tianyuan Biotechnology’s innovation and technical strength but also provides strong momentum for the company’s future growth. Next, Tianyuan Biotechnology will represent the Ninghai Division in the municipal-level competition in Ningbo. The entire company is confident about the upcoming contest. Dr. Chen stated, "We will continue to showcase Tianyuan’s innovative achievements with full enthusiasm and a professional attitude, striving for outstanding results in the municipal competition!"

      Tianyuan Biotechnology will seize this opportunity to further increase R&D investment, deepen technological innovation, and expand market applications. The company is committed to becoming a leader in the field of precision cell therapy, contributing greater strength to the cause of human health!